Journal of Pathology

Papers
(The H4-Index of Journal of Pathology is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Intravenous iron treatment fuels chronic kidney disease‐induced arterial media calcification in rats88
Novel prognostication biomarker adipophilin reveals a metabolic shift in uveal melanoma and new therapeutic opportunities78
Issue Information78
Breathing in danger: how particulate matter pollution is putting the public at risk of lung cancer†75
Collagen VI promotes recovery from colitis by inducing lymphangiogenesis and drainage of inflammatory cells68
Ovarian high‐grade serous carcinoma cells with low SMARCA4 expression and high SMARCA2 expression contribute to platinum resistance64
‘Know thyself’ – host factors influencing cancer response to immune checkpoint inhibitors63
The association between the tumor immune microenvironments and clinical outcome in low‐grade, early‐stage endometrial cancer patients55
CXCR4 mediates leukemic cell migration and survival in the testicular microenvironment55
Probing the tumorigenic potential of genetic interactions reconstituted in murine fallopian tube organoids53
Escape from senescence: molecular basis and therapeutic ramifications51
SMARCA4‐deficient rhabdoid tumours show intermediate molecular features between SMARCB1‐deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type51
Presence of Tim3+ and PD‐1+CD8+T cells identifies microsatellite stable colorectal carcinomas with immune exhaustion and di50
Spatial profiling of ANO7 in prostate tissue: links to AR‐signalling‐associated lipid metabolism and inflammation50
Integration of peripheral blood‐ and tissue‐based biomarkers of response to immune checkpoint blockade in urothelial carcinoma48
A new FGF15/19‐mediated gut‐to‐heart axis controls cardiac hypertrophy44
High‐resolution and quantitative spatial analysis reveal intra‐ductal phenotypic and functional diversification in pancreatic cancer43
Artificial intelligence to identify genetic alterations in conventional histopathology42
CRISPR–Cas9 screening identifies the role of FER as a tumor suppressor42
Integrating computational pathology and proteomics to address tumor heterogeneity41
Identification of tumour‐infiltrating myeloid subsets associated with overall survival in lung squamous cell carcinoma41
Genomic features of Helicobacter pylori‐naïve diffuse‐type gastric cancer40
Silencing GRHL3 promotes multiple organ distant metastasis of lung squamous cell carcinoma cells by enhancing SOX2 stability via SIRT138
38
Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response35
Pseudobudding: ruptured glands do not represent true tumor buds35
Human scattered tubular cells represent a heterogeneous population of glycolytic dedifferentiated proximal tubule cells35
Field cancerization in breast cancer33
In high‐grade ovarian carcinoma, platinum‐sensitive tumor recurrence and acquired‐resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and 33
Adrenomedullin2 stimulates progression of thyroid cancer in mice and humans under nutrient excess conditions31
The E2F1–HOXB9/PBX2–CDK6 axis drives gastric tumorigenesis and serves as a therapeutic target in gastric cancer31
31
0.19648098945618